share_log
Reuters ·  May 8 07:06
Syndax Pharmaceuticals Inc - for Q2 of 2024, Company Expects Research and Development Expenses to Be $50 to $55 Mln
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment